InBody BWA

What InBody BWA does

InBody BWA, Inc. is a Pennsylvania-domiciled private corporation that operates as the US medical division of South Korea-based InBody Co., Ltd. (founded 1990 by Dr. Kichul Cha). It supplies medical-grade body composition and body water analyzers to hospitals, clinics, physicians, and academic research institutions, with named customers including Cincinnati Children's Hospital, UCSF (MWCCS Study), Chester County Hospital, Mary Free Bed, and Rowan University. The company's core technology is patented multi-frequency bioelectrical impedance analysis (MF-BIA) using measured (not estimated) raw impedance values at frequencies up to 3,000 kHz, with Direct Segmental Measurement evaluating each body segment independently rather than as a single cylinder. The technology is validated at 98% correlation to DEXA (the body composition gold standard) and against D2O (the total body fluids gold standard) in multiethnic populations.

The product portfolio spans standing-use (InBody970, InBody770, InBody580), bedside (BWA2.0, InBody S10), and portable (InBody380, InBody270S) analyzers delivering over 100 body composition parameters in 70 seconds, plus peripheral products: the FRA System (fall risk assessment), InGrip (grip strength / frailty), BSM170B/BSM370 (digital stadiometers), BPBIO750/BPBIO320S (automated blood pressure), home-use devices (InBody Dial H30, Dial H20, Band3), and data management software (LB120 PC-based, LBWeb cloud-based, LookinBody application). The company reports a 1,500+ peer-reviewed journal footprint, 8,000+ validation studies, and 1.3M+ global body composition data points supporting clinical credibility.

Revenue is generated primarily through quote-based direct enterprise sales of high-ticket medical hardware on multi-year contracts, supplemented by subscription-based recurring revenue from LBWeb/LookinBody cloud platforms, an e-commerce storefront (shop.inbodybwa.com) for accessories and home-use devices, and professional services for technical support and data integration. Distribution combines a direct enterprise field sales motion (with inbound phone/email support and product recommendation tools), an e-commerce self-serve channel, and alignment with the parent InBody Co., Ltd.'s reach across 100+ countries. Pricing is not publicly disclosed and is structured per quote. The US subsidiary in Trooper, PA employs 1-10 people and reports no public revenue, funding rounds, M&A activity, or external institutional investment.

Name

InBody BWA

Legal name

InBody BWA Inc.

Website

https://inbodybwa.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

1–10 employees

Short description

InBody BWA is the US medical division of South Korea-based InBody Co., Ltd., selling medical-grade body composition and body water analyzers to hospitals, clinics, and research institutions using patented multi-frequency bioelectrical impedance technology validated to DEXA.

Ownership category

akta.pro rank

Product category

Medical Body Composition Analysis Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Other Measuring and Controlling Device Manufacturing (334519)

SIC

Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826), Industrial Instruments For Measurement, Display, And Control (3823)

akta.pro primary industry

Metrology, Calibration & Testing Equipment (Balances, pH/DO, Standards) (HLAGAIAL)

akta.pro secondary industries

Smart Scales & Body Composition Analyzers (CRACAQAA), Weighing & Force Measurement (Load cells, scales, torque, strain measurement) (IMAGAFAF)

Keywords

• Body composition analyzers
• Bioelectrical impedance analysis
• Medical water analyzers
• Clinical BIA devices
• Multi-frequency impedance systems

Headquarters

HQ city

Trooper

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical-Grade Body Composition Analyzers: Sale of standing, bedside, and portable body composition analyzers including InBody970, InBody770, InBody580, BWA2.0, InBody S10, InBody380, and InBody270S devices for medical and research facilities.
2. Accessories and Peripheral Devices: Sale of supporting products including FRA System for fall risk assessment, InGrip for grip strength measurement, BSM170B and BSM370 for digital height/BMI measurement, BPBIO750 and BPBIO320S for automated blood pressure, LB120 data management devices, and InBody wearable/home-use products.
3. Data Management Software and Cloud Services: LBWeb cloud-based data management platform and LookinBody applications providing data tracking, analysis, and integration capabilities. Revenue from software subscriptions and platform access fees.
4. Technical Support and Integration Services: Professional services including technical support, data integration consulting, and safety/sanitation guidance for medical facilities implementing InBody devices.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Core offering

InBody BWA designs, manufactures, and sells medical-grade bioelectrical impedance body composition and body water analyzers for hospitals, specialty clinical departments, and research institutions. Its core products measure skeletal muscle mass, body fat, intracellular/extracellular water, visceral fat, and phase angle using patented MF-BIA and Direct Segmental Measurement technology, and are sold alongside cloud-based (LBWeb) and PC-based (LB120) data management software, frailty assessment tools, digital stadiometers, and automated blood pressure monitors.

Product overview

InBody BWA (Body Water Analyzer) offers a comprehensive portfolio of medical-grade body composition and body water analyzers designed for clinical and research professionals. The product lineup includes standing-use analyzers (InBody970, InBody770, InBody580), bedside/body water analyzers (BWA2.0, InBody S10), and portable devices (InBody380, InBody270S) for flexible deployment across medical facilities. Supporting products include the FRA System for fall risk assessment with balance, body composition, and leg muscle dynamometer components; InGrip for frailty analysis; digital stadiometers (BSM170B, BSM370) for automated height and BMI; and automated blood pressure monitors (BPBIO750, BPBIO320S). Home-use products include InBody Dial H30, InBody Dial H20, and InBody Band3. Data management is handled through LB120 (PC-based) and LBWeb (cloud-based) platforms. The technology uses multi-frequency bioelectrical impedance analysis (MF-BIA) with frequencies up to 3MHz, validated at 98% to DEXA and in multiethnic populations to D2O gold standard.

Differentiator

Problem solved

Functional benefit

Brands

• LookinBody: Data management website and application platform for body composition data tracking and analysis.

Products and services

• InBody970

Quantifiable outcome

• 98% accuracy correlation to DEXA (Dual-Energy X-ray Absorptiometry) gold standard
• +3 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• LookinBody CompanycoreTechnology or IntegrationLookinBody Company provides data management infrastructure for InBody BWA, administering and maintaining servers that store body composition data. They help create, develop, operate, deliver, and improve InBody services, systems, and websites. The LookinBody web platform (https://usa.lookinbody.com) and LookinBody App are integral to InBody's data management ecosystem.
• InBody Co., Ltd.coreTechnology or IntegrationInBody Co., Ltd. is the parent company and technology licensor for InBody BWA. Founded by Dr. Kichul Cha in 1990, the company developed the core MF-BIA technology and holds patents. InBody Co., Ltd. utilizes extended security levels to protect electronic data and may share aggregated, de-identified data with partners for research and development purposes.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Tanita Corporation: Japanese manufacturer of bioelectrical impedance body composition analyzers for medical, research, fitness, and consumer use. Tanita is the closest direct competitor to InBody, with overlapping BIA technology, similar multi-frequency devices, and an equally global footprint.
• seca: German-based global leader in medical weighing and body composition. seca competes head-to-head with InBody in hospitals, clinics, and research institutions, offering medical-grade scales and BIA analyzers integrated into clinical workflows.
• RJL Systems: US-based manufacturer of clinical BIA analyzers used primarily in research and clinical nutrition. RJL competes directly with InBody's research-focused products such as the InBody770 and InBody S10.
• Bodystat: UK-based clinical BIA device maker serving hospitals, sports science, and research labs. Bodystat is a direct niche competitor in the medical/research body composition segment where InBody's BWA2.0 and InBody S10 compete.
• Akern: Italian developer of clinical BIA devices focused on body composition and fluid status assessment for medical and research use. Akern overlaps with InBody's bedside body water analyzers and segmental BIA offerings.

Broad incumbents

• Omron Healthcare: Global medical device incumbent with a broad portfolio spanning blood pressure monitors, body composition monitors, and connected health devices. Omron competes with InBody in clinical and home health segments, but body composition is one of many product lines.
• Hologic: Major medical technology company that manufactures DEXA bone densitometry and body composition systems, the gold standard against which InBody validates its BIA devices. Hologic competes at the high end of clinical body composition imaging.
• GE HealthCare: Global medical imaging and diagnostics incumbent, including DEXA and Lunar product lines used as the gold standard in body composition analysis. GE competes with InBody at the imaging-grade clinical end while InBody targets lower-cost, point-of-care BIA.

Emerging players

• Withings: French consumer health technology company known for smart scales and connected health devices with body composition features. Withings targets the consumer/connected-health end of InBody's market, competing with the InBody Dial home-use line.
• Garmin: Wearable technology company with smartwatches and scales offering body composition estimates integrated into its health ecosystem. Garmin competes with InBody's home-use and consumer wearables at the wellness end, though with less medical-grade validation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCxghR3g6bWFU-Oc7AObqmcg
• Facebookfacebook.com/inbodybwa1
• LinkedInlinkedin.com/company/inbodybwa
• Instagraminstagram.com/inbodybwa

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InBody BWA